This week, FDA advisory committee unanimously recommends Moderna booster shot; the USPSTF advises against aspirin for primary CVD prevention for adults 60 years or older; FDA permits marketing of new e-cigarette products; and more.

Read the full coverage here:

FDA advisory committee unanimously recommends Moderna booster shot

USPSTF advises against aspirin for primary CVD prevention for adults 60 years or older

FDA permits marketing of new e-cigarette products, marking first authorization of its kind

More than half of COVID-19 survivors experience symptoms 6 months after recovery

FDA issues new guidance on sodium, calls it ‘pivotal’ moment in US health

References:

FDA Press Release

USPSTF Statement

Press Release

Groff D, et al. JAMA Network Open. 2021;doi:10.1001/jamanetworkopen.2021.28568.

FDA Conference Call